CVE-2020-14525
Last modified
CVE-2020-14525 is a low-severity vulnerability rated 3.5/10 on the CVSS scale. Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.. EPSS estimates a 0.45% chance of exploitation in the next 30 days.
Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
Metrics
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Philips | Clinical Collaboration Platform | <= 12.2.1 |
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2020-14525?
How severe is CVE-2020-14525?
How do I fix CVE-2020-14525?
Are you affected by CVE-2020-14525?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
